Stephen (Steve) joined SpringWorks at the company’s launch in 2017 and served as Acting Head of Research and Development through April 2021. He is currently a venture partner with OrbiMed who brings over 25 years of biotechnology industry experience. Steve was also a co-founder of Alexion Pharmaceuticals, Inc. and served as its Executive Vice President and Chief Global Operations Officer. Prior to this role, he was Alexion’s Global Head of Research and Development. From 1988 to 1992, Steve held various positions at Regeneron Pharmaceuticals, Inc. Prior to Regeneron, he held a joint academic position at both Tulane University and LSU Medical Schools. He is a recipient of numerous honors and awards from academic and professional organizations for his scientific work. Steve received his Ph.D. in biochemistry and biophysics and B.A. in chemistry from Loyola University of Chicago.